SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,418.31 |
| Enterprise Value ($M) | 3,101.04 |
| Book Value ($M) | 832.98 |
| Book Value / Share | 8.98 |
| Price / Book | 4.10 |
| NCAV ($M) | 773.19 |
| NCAV / Share | 8.34 |
| Price / NCAV | 4.42 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.31 |
| Return on Assets (ROA) | -0.44 |
| Return on Equity (ROE) | -0.52 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 16.38 |
| Current Ratio | 16.38 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 877.59 |
| Assets | 937.37 |
| Liabilities | 104.39 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Wellington Management Group Llp | |||
| 13G/A | Fmr Llc | |||
| 13G/A | Vanguard Group Inc | |||
| 13G/A | EcoR1 Capital, LLC | 4.80 | 3.19 | |
| 13G | Price T Rowe Associates Inc /md/ | 6.20 | ||
| 13G/A | Point72 Asset Management, L.P. | 2.90 | -32.67 | |
| 13G/A | State Street Corp | 3.60 | -20.35 | |
| 13D/A | Perceptive Advisors Llc | 1.90 | -72.09 | |
| 13G/A | Driehaus Capital Management Llc | 7.54 | -10.41 | |
| 13G/A | Braidwell Lp | 0.00 | -100.00 | |
| 13G/A | Biotechnology Value Fund L P | 0.00 | -100.00 | |
| 13G/A | Orbimed Advisors Llc | 2.50 | -47.84 | |
| 13G/A | BlackRock, Inc. | 8.00 | 36.44 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K (Mark One) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 236,953 | 765,010 | 30.97 | |
| 146,393 | 486,885 | 30.07 | |
| 138,350 | 485,030 | 28.52 | |
| 157,308 | 687,450 | 22.88 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CPIX – Cumberland Pharmaceuticals Inc. | CRBU – Caribou Biosciences, Inc. |
| CRGX – CARGO Therapeutics, Inc. | CTMX – CytomX Therapeutics, Inc. |
| CYTK – Cytokinetics, Incorporated |
Financial data and stock pages provided by
Fintel.io